Keyphrases
Pseudomonas Aeruginosa (P. aeruginosa)
100%
COVID-19
85%
Whole Genome Sequencing
44%
Klebsiella Pneumoniae (K. pneumoniae)
37%
Variants of Concern
34%
COVID-19 Pandemic
30%
Virulence
27%
Pneumonia
25%
Clostridioides Difficile
25%
Multidrug-resistant
24%
United States
21%
Klebsiella Pneumoniae Carbapenemase
20%
Aminoglycosides
20%
Draft Genome Sequence
19%
Complete Genome Sequence
19%
Lung
19%
Clostridium Innocuum
19%
Genome Analysis
17%
Genomic Surveillance
16%
Trend Analysis
15%
Genome Sequencing
15%
Virus
15%
Virulence Determinants
15%
Surveillance Metrics
15%
3OC12-HSL
15%
Sequence Type
14%
Genomic Characterization
14%
Acinetobacter Baumannii (A. baumannii)
14%
Difficile
14%
Baumannii
14%
Comparative Genomic Approach
14%
Contact-dependent Growth Inhibition
14%
Longitudinal Trends
14%
Neisseria Gonorrhoeae
14%
Pseudomonas Aeruginosa Isolates
14%
Pandemic 2020
14%
Meropenem
14%
C.difficile Infection
13%
SARS-CoV-2 Genome
13%
Accessory Genome
13%
World Health Organization
13%
Quorum Sensing
13%
Blood Isolates
12%
Cystic Fibrosis
12%
Clinically Significant
12%
Clinical Outcomes
12%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
12%
Gentamicin
12%
Paraoxonase 1 (PON1)
11%
Disease Severity
11%
Immunology and Microbiology
Pseudomonas aeruginosa
91%
Severe Acute Respiratory Syndrome Coronavirus 2
63%
Klebsiella pneumoniae
47%
Whole Genome Sequencing
34%
Lineages
33%
COVID-19
24%
Cladistics
20%
Antimicrobial Resistance
19%
Acinetobacter Baumannii
19%
Clostridium innocuum
19%
Infectious Agent
17%
Genetic Variability
15%
Neisseria gonorrhoeae
14%
Minimum Inhibitory Concentration
13%
Population Structure
12%
Phylogeny
11%
Pilin
11%
Plasmid
11%
Peptoclostridium difficile
11%
Immunology
10%
Spike
10%
Transposon
10%
Single Nucleotide Polymorphism
10%
Omicron Coronavirus Variant
9%
Pseudomonas
9%
Antigenic Variation
9%
Bacteriophage
9%
Restriction Mapping
9%
Multidrug Resistance
9%
Molecular Epidemiology
9%
Genomic Surveillance
8%
Antibody Titer
8%
Viral Load
8%
Antitoxin
7%
Genome Sequencing
7%
Virulence Factor
7%
Soft Tissue
7%
Pilus
7%
Human Immunodeficiency Virus
5%
Pathogenicity
5%
Bacterial Strain
5%
Macrophage
5%
Neutralizing Antibody
5%
Illumina MiSeq
5%
Acinetobacter
5%
Acinetobacter Calcoaceticus
5%
Infectious Disease
5%
Type Three Secretion System
5%